Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | -2.58% | 24.92 | 14.1% | $146.63m | |
| ICLR | ICON plc | -0.44% | 255.92 | 2.8% | $144.79m | |
| HZNP | Horizon Therapeutics Plc | -1.67% | 86.57 | 5.4% | $106.97m | |
| CTLT | Catalent, Inc. | -0.48% | 102.07 | 2.0% | $104.75m | |
| BHC | Bausch Health Cos., Inc. | -2.58% | 24.92 | 0.0% | $102.00m | |
| SAVA | Cassava Sciences, Inc. | -9.13% | 37.41 | 0.0% | $90.10m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.07% | 139.13 | 2.1% | $86.34m | |
| UTHR | United Therapeutics Corp. | -2.49% | 199.97 | 13.9% | $78.20m | |
| ZGNX | Zogenix, Inc. | 0.31% | 26.00 | 7.5% | $67.37m | |
| ARGX | argenx SE | 0.99% | 281.48 | 0.0% | $50.38m | |
| PRGO | Perrigo Co. Plc | -0.18% | 39.73 | 6.9% | $48.99m | |
| PCRX | Pacira Biosciences, Inc. | -0.41% | 64.00 | 9.8% | $28.57m | |
| BRBR | BellRing Brands, Inc. | -2.02% | 24.25 | 0.0% | $26.01m | |
| IRWD | Ironwood Pharmaceuticals, Inc. | -2.41% | 10.92 | 9.5% | $22.19m | |
| CORT | Corcept Therapeutics, Inc. | -2.35% | 17.47 | 5.5% | $18.09m |
Company Profile
CytRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.